Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at CHF 19.1B, ahead of BioNTech (CHF 18B) and Biogen (CHF 15.4B). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesCHF 19.1B
Median
CHF 1.7B
Combined market value
CHF 716B
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareCHF 19.1BCHF 178.1BCHF 143.57 1.60% up 33% up United States
2BioNTechBNTX · Health CareCHF 18BCHF 17.7BCHF 71.56 0.47% down 16% down Germany
3BiogenBIIB · Health CareCHF 15.4BCHF 31.3BCHF 211.47 0.34% down 49% up United States
4AmgenAMGN · Health CareCHF 7.3BCHF 208.9BCHF 386.14 0.95% down 34% up United States
5ModernaMRNA · Health CareCHF 7.3BCHF 70.6BCHF 174.38 3.93% down 755% up United States
6argenxARGX · Health CareCHF 6.2BCHF 50.2BCHF 798.97 0.36% down 4% up Belgium
7QiagenQGEN · Health CareCHF 3.2BCHF 8.7BCHF 41.95 0.12% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareCHF 2.7BCHF 14.2BCHF 139.91 0.37% up 20% up United States
9VaxcytePCVX · Health CareCHF 2.3BCHF 7.9BCHF 50.09 3.59% down 22% up United States
10ExelixisEXEL · Health CareCHF 1.8BCHF 14.1BCHF 57.76 2.09% up 63% up United States
11Bio-TechneTECH · Health CareCHF 1.8BCHF 9.6BCHF 61.24 0.22% down 26% up United States
12RepligenRGEN · Health CareCHF 1.8BCHF 8.7BCHF 136.75 0.37% down 5% up United States
13CRISPR TherapeuticsCRSP · Health CareCHF 1.6BCHF 3.3BCHF 33.86 0.54% down 21% down Switzerland
14Revolution MedicinesRVMD · Health CareCHF 1.4BCHF 29.7BCHF 137.18 2.50% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareCHF 1.3BCHF 8.7BCHF 102.47 3.44% down 87% up United States
16Krystal BiotechKRYS · Health CareCHF 1BCHF 7.5BCHF 251.74 0.22% up 46% up United States
17ImmunovantIMVT · Health CareCHF 718.9MCHF 5.8BCHF 28.00 0.21% down 43% up United States
18CG OncologyCGON · Health CareCHF 634.6MCHF 5.9BCHF 66.56 6.89% down 85% up United States
19Twist BioscienceTWST · Health CareCHF 398.8MCHF 6.4BCHF 94.44 6.63% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareCHF 207MCHF 4.6BCHF 38.01 1.21% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareCHF 184.5MCHF 3.9BCHF 24.02 2.22% up 88% up United States
22Kodiak SciencesKOD · Health CareCHF 132.7MCHF 5.3BCHF 81.62 3.90% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareCHF 41.2MCHF 9.2BCHF 80.92 0.55% down 37% up United States
24ImmunityBioIBRX · Health Care-CHF 422MCHF 5.6BCHF 5.28 4.68% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8432 CHF).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (CHF 19.1B), BioNTech (CHF 18B) and Biogen (CHF 15.4B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 14:23 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of CHF 716B as of 18 Nov 2026, 14:23 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.